small molecule glp-1 receptor agonist Oral Small-Molecule Agonists: Mechanistic Insights and Emerging Therapeutic Strategies How GLP-1 Receptor Agonists Evolved
Description
Eli Lillys SURMOUNT-MMO data, showing a 38% cut in cardiovascular death and heart-failure hospitalization with tirzepatide, further validated the class
From there, doses increased in 2-week intervals until reaching the target maintenance dose
Tirzepatide was FDA-approved for T2D in 2022, and showed impressive weight reductions in subsequent obesity trials
2023, Furusawa et al
Whats the difference between Wegovy and other GLP-1 weight loss medications
Current program details, pricing, and enrollment terms can be confirmed by viewing the current Found Health program offer (official Found page)
